Miracor's coronary sinus occlusion system treats 1st patient in U.K.

December 26, 2012 by MassDevice staff

Miracor's PICSO coronary sinus occlusion system treats the 1st U.K. large acute heart attack patient following a CE Mark win in the European Union.

Miracor Medical Systems logo

Private medical device maker Miracor Medical Systems GmbH won CE Mark approval for its Pressure-controlled Intermittent Coronary Sinus Occlusion System.

In conjunction with the regulatory win, the company announced that it successfully treated its 1st patient, a U.K. woman who suffered a large acute heart attack.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.